# Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities

> **NCT05207176** · PHASE1 · UNKNOWN · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DWP16001

## Key facts

- **NCT ID:** NCT05207176
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-14
- **Primary completion:** 2022-04-08
- **Final completion:** 2022-08-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05207176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05207176, "Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05207176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*